Category: us corporate news

us corporate news

Fennec Pharmaceuticals 2025 Annual Report: PEDMARK® Commercialization, Risks, and Intellectual Property Overview

Minichart

March 28, 2026

Fennec Pharmaceuticals 2025 Annual Report: Key Highlights an...

Continue Reading 0

us corporate news

Empery Digital Inc. 2025 Annual Report: Bitcoin Treasury Strategy, E-Bike Business, and Key Risks Overview

Minichart

March 28, 2026

Empery Digital Inc. 2025 10-K: Investor-Focused Detailed Rep...

Continue Reading 0

us corporate news

MUZE Acquisition Corp: SPAC Overview, Business Combination Process, Risks, and Competitive Strengths (2026 SEC Filing)

Minichart

March 28, 2026

MuZero Capital 10-K Report: Detailed Investor Summary ...

Continue Reading 0

us corporate news

Humacyte, Inc. 2025 Annual Report: Business Overview, Risk Factors, Financials, and SEC Filings

Minichart

March 28, 2026

Humacyte, Inc. Files Annual Report (Form 10-K) for Fiscal Ye...

Continue Reading 0

us corporate news

Verde Clean Fuels, Inc. 2025 Annual Report: STG+® Technology, Capital-Lite Strategy, and Key Business Risks

Minichart

March 28, 2026

Verde Clean Fuels, Inc. 2025 Annual Report - Key Investor In...

Continue Reading 0

us corporate news

Healthier Choices Management Corp. 2025 Annual Report – Intellectual Property Strategy, Vaporizer Business, and Corporate Governance Overview

Minichart

March 28, 2026

HCMC 2025 Annual Report: Key Investor Insights Healthier...

Continue Reading 0

us corporate news

Vine Hill Capital Investment Corp. 10-K Annual Report: Business Strategy, Risk Factors, and SPAC Merger with CoinShares Overview

Minichart

March 28, 2026

Vine Hill Capital Investment Corp. Annual Report: Key Highli...

Continue Reading 0

us corporate news

Bank of the James Financial Group, Inc. 2025 Annual Report: Financial Overview, Risk Factors, and Corporate Information (BOTJ)

Minichart

March 28, 2026

Key Points from the 2025 Annual Report BOTJ filed its 10-...

Continue Reading 0

us corporate news

Hoth Therapeutics 2025 Annual Report: Clinical-Stage Biopharmaceutical Pipeline, FDA Regulatory Pathways, and Risk Factors Overview

Minichart

March 28, 2026

Hoth Therapeutics, Inc. 2025 Annual Report: Key Investor Ins...

Continue Reading 0

us corporate news

Manhattan Bridge Capital: Real Estate Finance, Hard Money Lending, and Competitive Strategies in the NY Metropolitan Market

Minichart

March 28, 2026

Manhattan Bridge Capital, Inc. 10-K Report: Key Investor Det...

Continue Reading 0